【ChiCTR2500112911】Effectiveness of a Medical-Social Collaboration in Improving the Well-Being of People with Cognitive Impairment
ChiCTR2500112911
尚未开始
/
/
/
2025-11-20
/
/
dementia
Effectiveness of a Medical-Social Collaboration in Improving the Well-Being of People with Cognitive Impairment
Effectiveness of a Medical-Social Collaboration in Improving the Well-Being of People with Cognitive Impairment
1. To investigate the effectiveness of a tailored intervention offered by an NGO in the hospital wards (medical-social collaboration) in improving the well-being of inpatients with cognitive impairment and their caregivers. 2. To examine the effectiveness of the intervention in reducing negative outcomes such as delirium, and facilitating ageing in place 3. To explore the feasibility of implementing this medical-social collaboration model.
单臂
其它
No randomization
/
NA
/
250;30
/
2025-12-01
2028-12-31
/
Inpatients with cognitive impairment (N=250) 1. Aged 60 years old or above 2. People with ICD label of cognitive impairment, delirium, or confusion 3. Stayed in Shatin Hospital’s medicine and geriatrics wards Caregivers of inpatients with cognitive impairment (N=250) 1. Aged 18 years old or above 2. Caregivers of inpatient participants of this study Staff of Shatin Hospital (N=30) 1. Aged 18 years old or above 2. Staff of Shatin Hospital 3. Involved in this intervention programme, such as taking care of the participants, or offering intervention to them, or participating in the planning of the intervention of this programme；
请登录查看Inpatients with cognitive impairment (N=250) 1. Admission from elderly home 2. Unable to take part in intervention or research data collection 3. Not giving consent to research participation Caregivers of inpatients with cognitive impairment (N=250) 1. Unable to take part in intervention or research data collection 2. Not giving consent to research participation Staff of Shatin Hospital (N=30) 1. Not giving consent to research participation；
请登录查看Jockey Club Centre for Positive Ageing
/
Jockey Club Centre for Positive Ageing的其他临床试验
Jockey Club Centre for Positive Ageing的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04